A Prospective, Multicentral, Open-label, Randomized, Controlled, Phase III Clinical Trial to Compare S-1 Plus Oxaliplatin to S-1 as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer

Trial Profile

A Prospective, Multicentral, Open-label, Randomized, Controlled, Phase III Clinical Trial to Compare S-1 Plus Oxaliplatin to S-1 as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 28 Oct 2016

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin (Primary)
  • Indications Gastric cancer
  • Focus Therapeutic Use
  • Acronyms CAPITAL
  • Most Recent Events

    • 23 Oct 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Nov 2016.
    • 23 Oct 2016 Status changed from recruiting to active, no longer recruiting.
    • 25 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top